Antiproteinuric effect of RAS blockade: New mechanisms
Authors:
- 1 September 2004
- journal article
- research article
- Published by Springer Nature in Current Hypertension Reports
- Vol. 6 (5) , 383-392
Abstract
Experimental and clinical studies have shown that blockade of the renin-angiotensin system (RAS) is effective in reducing proteinuria in conditions such as diabetes by reducing systemic and intraglomerular hydrostatic pressure. However, increasing evidence suggests that nonhemodynamic effects, such as preservation of the podocyte slit diaphragm structure and function, may also mediate the antiproteinuric effects of RAS blockade. In this review, we analyze in detail the evidence for known and novel mechanisms considered to play important roles in mediating the antiproteinuric effect of RAS blockers, with a particular focus on diabetic nephropathy.Keywords
This publication has 106 references indexed in Scilit:
- Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathyKidney International, 2004
- Retinal Expression of Vascular Endothelial Growth Factor Is Mediated by Angiotensin Type 1 and Type 2 ReceptorsHypertension, 2004
- Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytesExperimental & Molecular Medicine, 2004
- Nitric Oxide May Prevent Hypertension Early in Diabetes by Counteracting Renal Actions of SuperoxideHypertension, 2004
- Angiotensin II Increases Connective Tissue Growth Factor in the KidneyThe American Journal of Pathology, 2003
- Role of Advanced Glycation End Products in Diabetic NephropathyJournal of the American Society of Nephrology, 2003
- Reactive Oxygen Species-Regulated Signaling Pathways in Diabetic NephropathyJournal of the American Society of Nephrology, 2003
- Enalapril Attenuates Oxidative Stress in Diabetic RatsHypertension, 2001
- Transcription factor-κB (NF-κB) and renal diseaseKidney International, 2001
- Angiotensin II Increases Vascular Permeability Factor Gene Expression by Human Vascular Smooth Muscle CellsHypertension, 1995